Dilip J. Mehta

Plus aucun poste en cours

Profil

Dr. Mehta became a Radius Venture Partner in 2004.
He is the former Senior Vice President of US Clinical Research at Pfizer, Inc., where he was responsible for clinical research (Phase I, II and III), including the design and implementation of clinical protocols, statistical analysis and data processing, and submissions of New Drug Applications for Pfizer's pharmaceutical pipeline.
During Dr. Mehta's tenure at Pfizer, he supervised NDA submissions for many of the company's current top-selling drugs, including Norvasc, Zololft, Zithromax, Diflucan and Viagra.
Dr. Mehta managed a staff of over 450 scientists with an annual budget in excess of $350 million, and established clinical research teams in Canada, China, India and Latin America.
Dr. Mehta currently serves on the Psychopharmacology Advisory Committee of the FDA, is a member of the board of directors of Spectrum Pharmaceuticals, Inc., Esvee Pharmaceuticals Pvt Ltd.
(India), Bharat Serums & Vaccines Limited (India), and is a member of the Scientific Board of Myomatrix Molecular Technologies LLC.
mpany's current top-selling drugs, including NorvascT, ZoloftT, ZithromaxT, DiflucanT and ViagraT.
Dr. Mehta currently serves on the board of Targanta, Inc., which is a Radius portfolio company, as well as a number of U.S.
and international biotechnology companies.
Dr. Mehta received his M.B.B.S., M.D.
and Ph.D.
from the University of Bombay.

Anciens postes connus de Dilip J. Mehta

Sociétés	Poste	Fin
SPECTRUM PHARMACEUTICALS, INC.	Directeur/Membre du Conseil	22/06/2012
Targanta Therapeutics Corp.	Directeur/Membre du Conseil	26/02/2009
Bharat Serums & Vaccines Ltd.	Directeur/Membre du Conseil	01/01/2008
SPECTRUM PHARMACEUTICALS, INC.	Directeur/Membre du Conseil	01/07/2007
Quintiles Spectral India Pvt Ltd.	Président	01/01/2001

Formation de Dilip J. Mehta

University of Mumbai

Doctorate Degree